1
CARDIOVASCULAR
hamburger

Welcome to the virtual AAHFN 2020 Advanced Heart Failure Symposium Experience from Abbott

With the shift to a virtual 2020 American Association of Heart Failure Nurses (AAHFN) Advanced Heart Failure Symposium due to COVID-19, we know having easy access to relevant clinical information is important. We have included details for the Abbott sponsored symposium and highlighted key webinars below.

American Association of Heart Failure Nurses
Abbott-Sponsored Symposium

Helping Your Patients Understand the Risks: Your Recommendation Matters

Virtual Symposium at the AAHFN Advanced Heart Failure Symposium

Friday, Nov. 6 | 12:50-1:50 p.m. EST

Dr. Edward Soltesz
Abbott-Sponsored Symposium

Optimizing Management of HF Patients Leveraging Remote Monitoring

Did you miss our Abbott-Sponsored symposium at the Annual meeting?

Listen to the recording of the presentation by Diane Czaplicki, RN, BSN and Christina Sauld, APNP who discussed CRT and PA pressure monitoring and the role these therapies can play in the management of heart failure. They also addressed the role of the nurse in identifying and advocating for heart failure patients.

Webinar Highlight

Remote Management of Heart Failure Patients Using the CardioMEMS™ HF System Today and Beyond

In an interactive presentation, Jacob Abraham, MD, a cardiologist with extensive experience using the CardioMEMS™ HF System, shares his best practices for remote monitoring and telemedicine in the clinical management of heart failure patients. He will review the importance of keeping patients out of the hospital and how to maintain good patient outcomes in this current pandemic climate.

Find additional CardioMEMS™ HF System education and training resources.

Webinar Highlight

On Call Scenarios for VAD Coordinators Caring for Patients with Left Ventricular Assist Devices

An interactive discussion with Tim Robbins, BSN, CCRN, sharing his experience and ideas for managing LVAD patients in emergency situations.

Find additional HeartMate 3™ LVAD education and training resources.

Webinar Highlight

Managing Advanced Heart Failure: Mechanical Circulatory Support (MCS) Coordinator Symposium

This webinar built upon existing knowledge and use of the continuous-flow ventricular assist devices, specifically HeartMate™ Left Ventricular Assist System (LVAS). Expert speakers addressed best practice solutions and case studies discussing post-operative patient and system management to improve patient care.

Find additional HeartMate 3™ LVAD education and training resources.

Indications, Safety & Warnings

Rx Only

Brief Summary: Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.

CardioMEMS™ HF System Indications and Usage: The CardioMEMS™ HF System is indicated for wirelessly measuring and monitoring pulmonary artery (PA) pressure and heart rate in New York Heart Association (NYHA) Class III heart failure patients who have been hospitalized for heart failure in the previous year. The hemodynamic data are used by physicians for heart failure management and with the goal of reducing heart failure hospitalizations.

CardioMEMS™ HF System Contraindications: The CardioMEMS HF System is contraindicated for patients with an inability to take dual antiplatelet or anticoagulants for one month post implant.

CardioMEMS™ HF System Potential Adverse Events: Potential adverse events associated with the implantation procedure include, but are not limited to, the following: Infection, Arrhythmias, Bleeding, Hematoma, Thrombus, Myocardial infarction, Transient ischemic attack, Stroke, Death, and Device embolization.

HeartMate 3™ LVAS Indications: The HeartMate 3 Left Ventricular Assist System is indicated for providing short-and long-term mechanical circulatory support (e.g., as bridge to transplant or myocardial recovery, or destination therapy) in patients with advanced refractory left ventricular heart failure.

HeartMate 3™ LVAS Contraindications: The HeartMate 3 Left Ventricular Assist System is contraindicated for patients who cannot tolerate, or who are allergic to, anticoagulation therapy.

HeartMate 3™ LVAS Adverse Events: Adverse events that may be associated with the use of the HeartMate 3 Left Ventricular Assist System are: death, bleeding, cardiac arrhythmia, localized infection, right heart failure, respiratory failure, device malfunctions, driveline infection, renal dysfunction, sepsis, stroke, other neurological event (not stroke-related), hepatic dysfunction, psychiatric episode, venous thromboembolism, hypertension, arterial non-central nervous system (CNS) thromboembolism, pericardial fluid collection, pump pocket or pseudo pocket infection, myocardial infarction, wound dehiscence, hemolysis (not associated with suspected device thrombosis) or pump thrombosis.

MAT-2010924 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2019 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.